Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation

Journal of Perinatal Medicine

Volumn 36, Issue 5, 2008, Pages 419-424

  Morikawa, Mamoru ^a,b   Yamada, Takashi ^a   Yamada, Takahiro ^a   Cho, Kazutoshi ^a   Yamada, Hideto ^a   Sakuragi, Noriaki ^a   Minakami, Hisanori ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antithrombin activity; Clinical outcome; Gestational hypertension; Gestational proteinuria, preeclampsia; Pregnancy induced hypertension; Presumptive diagnosis

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; GESTATION PERIOD; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEINURIA;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROTEINURIA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 51549110010     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2008.062     Document Type: Article

References (22)

1. Barton JR, O'brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol. 2001;184:979-83.
2. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. Austalasian Society of the Study of Hypertension in Pregnancy. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol. 2000;40:139-55.
3. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Preg. 2001;20:9-14.
4. Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol. 1993;100:416-20.
5. Castro MA, Goodwin TM, Shaw KJ, Ouzounian JG, McGehee WG. Disseminated intravasucular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol. 1996;174:211-6.
6. Chesley LC. Diagnosis of preeclampsia. Obstet Gynecol. 1985;65:423.
7. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. Br Med J. 1994;309:1395-400.
8. Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol. 1990;162:366-71.
9. Ho CH, Yang ZL. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost. 1992;67:214-8.
10. Kullberg G, Lindeberg S, Hanson U. Eclampsia in Sweden. Hypertens Preg. 2002;21:13-21.
11. Minakami H, Kohmura Y, Izumi A, Watanabe T, Matsubara S, Sato I. Relation between gestational thrombocytopenia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome). Gynecol Obstet Invest. 1998;46:41-5.
12. Minakami H, Watanabe T, Izumi A, Matsubara S, Koike T, Sayama M, et al. Association of a decrease in antithrombin III activity with a perinatal elevation in aspartate aminotransferase in women with twin pregnancies: relevance to the HELLP syndrome. J Hepatol. 1999:30:603-11.
13. Minakami H, Yamada H, Suzuki S. Gestational thrombocytopenia and pregnancy-induced antithrombin deficiency: progenitors to the development of the HELLP syndrome and acute fatty liver of pregnancy. Semin Thromb Hemost. 2002;28:515-8.
14. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990;163:1691-712.
15. Osmanagaoglu MA, Topcuoglu K, Ozeren M, Bozkaya H. Coagulation inhibitors in preeclamptic pregnant women. Arch Gynecol Obstet. 2005;271:227-30.
16. Paternoster DM, Stella A, Simioni P, Mussap M, Plebani M. Coagulation and plasma fibronectin parameters in HELLP syndrome. Int J Gynaecol Obstet. 1995;50:263-8.
17. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-22.
18. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46:1263-9.
19. Sato K. New name, definition and classification of 'Pregnancy-induced Hypertension (PIH)', which aimed at international universality. Nippon Syusanki Shinseiji Gakkai Zasshi. 2005;41:667-74 (in Japanese).
20. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol. 1998;105:1177-84.
21. Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW. Plasma antithrombin III levels in pre-eclampsia. Clin Exp Hypertens B. 1983;2:145-62.
22. Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol. 1984;148:1092-7.